Clinical Research Directory
Browse clinical research sites, groups, and studies.
Comparison of Outcomes Between Topical Minoxidil Versus Oral Minoxidil for the Treatment of Androgenetic Alopecia
Sponsor: Sheikh Zayed Federal Postgraduate Medical Institute
Summary
To compare the outcome of topical minoxidil 5% spray versus oral minoxidil 2.5 mg tablet for the treatment of androgenetic alopecia in males and females. Outcomes include efficacy of the treatment, measured by reduction in hair shedding, improvement in hair density and new hair growth as assessed by physican and patient assessment as well as safety, defined as incidence and severity of adverse events over a treatment period of 6 months
Key Details
Gender
All
Age Range
18 Years - 50 Years
Study Type
INTERVENTIONAL
Enrollment
200
Start Date
2025-12-20
Completion Date
2026-06-01
Last Updated
2025-12-10
Healthy Volunteers
No
Conditions
Interventions
Minoxidil 5 % Topical Spray
Topical spray on hairs
minoxidil
Oral minoxidil 2.5mg
Placebo Spray
placebo spray
Placebo Tablet or Capsule
Placebo tablet